PharmaNutra presents: SiderAL, the only Sucrosomial® Iron

2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position.

Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent worldwide. Oral iron salts, especially ferrous sulfate, are commonly used for the treatment of iron deficiency (ID). However, its use is associated with gastrointestinal side effects, thus compromising treatment compliance. Sucrosomial® iron is an oralformulation consisting of ferric pyrophosphate conveyed by a phospholipid and sucrester matrix (sucrosome®).

PharmaNutra S.p.A. communicates the publication of a new, important scientific study on the use of ApportAL® for the treatment of post Covid-19 chronic fatigue, also known as “chronic Covid syndrome” or “Long Covid”.

Cetylated Fatty Acids (CFAs) have shown to reduce pain by decreasing the production of key mediators. Theyhave been successful in improving many conditions including athletic pubalgia, shoulder tendinopathies, and osteoarthritis,but their effects on axial discogenic back pain have never been studied. This study aims to investigate if the short termsupplementation of oral CFAs reduces pain and disability in patients with axial discogenic low back pain.

The innovative Sucrosomial® Magnesium developed by the PharmaNutra Group is one of the main ingredients of the new Multicentrum MyMAG launched by Pfizer.

Recent studies have verified that the SARS-CoV-2 infection can havemedium-term and long-term effects, collectively referred to as “post-Covid syndrome” or “long-Covid”. Studies conducted on both patients dischargedfrom hospital and patients managed at home showed that there was no association between theseverity of the Coronavirus disease (Covid-19) and the subsequent chronic fatigue symptom. The aim ofthis study was to evaluate the ability of a nutritional supplement based on vitamins, minerals, aminoacids and plant extracts (Apportal®) intake, to ameliorate the general health status in particular thechronic fatigue symptom in subjects after SARS-CoV-2 negativity.

We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3formulations in Vit D-deficient healthy adults.

PharmaNutra, established in 2003, develops unique nutritional supplements and innovative medical devices, handling the entire production process, from proprietary raw materials to the finished product.

SiderAL®️ dietary supplement contains Sucromial®️Iron and it helps the body to restore the normal iron level. It is characterized by excellent gastrointestinal tolerability without the common side effects associated with iron intake. SiderAL®️ is useful in all situations of deficiency or increased need for iron.

Apportal®️ thanks to its 19 nutrients gives an important support to the body. A published trial demonstrates an improvement in chronic asthenia, after 28 days of supplementation, in 90% of subjects who have been affected by Covid-19 disease (Long-Covid syndrome), improving their quality of life.

Lipocet®️ is a proprietary blend of Cetilated Fatty Acids (CFA), recently approved as Novel Food in Europe and is also a GRAS ingredient in USA. CFA allow for normal joints lubrication, flexibility and mobility. A great result to develop a new category of dietary supplement.